Skip to content

FD 86 - Tirzepatida ou orforglipron ajudam a manter o peso perdido?

May 20, 2026 · 10 min

Show notes

Não esqueça de nos avaliar com 5*, seguir @endodirect e ativar o sininho de notificações!>Neste FD resumimos os principais achados dos estudos ATTAIN MAINTAIN e SUSTAIN MAINTAIN, que foram publicados e apresentados no Congresso Europeu de Obesidade e avaliaram a orforgliprona e a tirzepatida na manutenção do peso perdido em pacientes que já estavam em tratamento da obesidade com análogos do GLP-1 injetáveis.


All episodes of EndoDirect – Endocrinologia e Metabologia

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.